5-Bromo-3-methyl-2-[(piperidin-1-yl)carbonyl]pyridine, 95+%, 10g

2,4,5-Trifluorobenzylamine, 97.0%, 25g

iScope IS.1153-PLPHi Triocular with Plan phase IOS objectives and Rackless cross table (infinity)

6-Fluoro-[1,2,4]triazolo[1,5-a]pyridine, 98%, 250mg

4-(3-CHLORO-PROPYL)-4-CYANO-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 90.0%, 500mg

1-Methyl-1H-pyrazole-4-carbonitrile, 95.0%, 25g

(1H-Pyrrolo[2,3-b]pyridin-5-yl)boronic acid, 95.0%, 10g

4-Methoxyphenylacetone, 98.0%, 100g

2-(4-methylphenyl)imidazo[1,2-{a}]pyridin-3-amine, 95.0%, 1g

Methyl (R)-(+)-2-chloropropionate, 97.0%, 25g

2-Amino-6-nitro-benzaldehyde, 97.0%, 1g

8-Nitro-4-phenyl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline, 98%, 1mg

(S)-2,2,2-Trifluoro-1-(4-chloro-phenyl)-ethylamine hydrochloride, 96%, 250mg